WEB SEARCH


TOP SELECTION

CONTACT US

info_demofinance@mynasdaq.it

DONATION

All profits of this web site are donated to charity 'the arsenal of peace'. VISIT THE WEBSITE

ADS

Complete financial analysis of ISTA PHARMACTLS (ISTA)

Name ISTA PHARMACTLS
Year low 2.88
Year High 9.42
Symbol ISTA
Last trade 9.08
Percentage change -0.11
Volume 31,552
Media Volume (3m) 1,299,100
PE Ratio 38.19
EPS 0.238
Market Cap 380
Media fatt 160
Trend fatt trend fatt graph for ISTA PHARMACTLS
Media net income -4
Trend net income trend net income for ISTA PHARMACTLS
P / E P / E graph for ISTA PHARMACTLS - 6 points 6
EPS EPS graph for ISTA PHARMACTLS - 8 points 8
MARKET CAP / TOTAL REVENUE market  cap  /  total  revenue  graph for ISTA PHARMACTLS - 4 points 4
TOT REV 1 / TOT REV 2 TOT REV 1 / TOT REV 2 graph for ISTA PHARMACTLS - 1 points 1
NET INC 1 / NET INC 2 NET INC 1 / NET INC 2 graph for ISTA PHARMACTLS - 4 points 4
MED NET INC / MED TOT REV MED NET INC / MED TOT REV graph for ISTA PHARMACTLS - 0 points 0
NET INCOME / MARKET CAP NET  INCOME  /  MARKET  CAP graph for ISTA PHARMACTLS - 0 points 0
TOTALREV1/TOTALREV3 totalRev1/totalRev3 graph for ISTA PHARMACTLS - 1 points 1
NET INC1/NET INC3 net inc1/net inc3 graph for ISTA PHARMACTLS - 0 points 0
TOT REV 2/ TOT REV 3 tot rev 2/ tot rev 3 graph for ISTA PHARMACTLS - 5 points 5
NET INC 2 / NET INC 3 net inc 2 / net inc 3 graph for ISTA PHARMACTLS - 0 points 0
. . graph for ISTA PHARMACTLS - 0 points 0
MARKET CAP / NET TANGIBLE ASSETS MARKET CAP / NET TANGIBLE ASSETS graph for ISTA PHARMACTLS - 4 points 4
MARK CAP/TOT STOCK EQ MARK CAP/TOT STOCK EQ graph for ISTA PHARMACTLS - 0 points 0
MARKET CAP / TOT CURRENT ASSETS market cap / tot current assets graph for ISTA PHARMACTLS - 0 points 0
TOT CURR ASSETS / TOT LIAB TOT CURR ASSETS / TOT LIAB graph for ISTA PHARMACTLS - 1 points 1
. . graph for ISTA PHARMACTLS - 0 points 0
SELL HOLD BUY SELL           HOLD          BUY graph for ISTA PHARMACTLS - 0 points 0
SINTESE 34

GRAPHS

max price logarithm graph for ISTA PHARMACTLS based on no conditions max volume linear graph for ISTA PHARMACTLS based on no conditions

News

ISTA Pharmaceuticals Highlights PROLENSA(TM) Clinical Data at the 2012 Association for Research in Vision and (May 10 - reuters) ISTA Pharmaceuticals Reports First Quarter 2012 Financial Results (May 03 - reuters) ISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase 2 Clinical Trial of BEPOSONE(TM) Nasal Spray for (May 01 - reuters) Bausch + Lomb and ISTA Pharmaceuticals Announce Early Termination of Hart-Scott-Rodino Waiting Period (Apr 24 - reuters) ISTA Pharmaceuticals Highlights PROLENSA(TM) Clinical Data at the 2012 American Society of Cataract and Refractive (Apr 23 - reuters) Bausch & Lomb launches $3.48 billion credit (Apr 19 - reuters) RLPC: Bausch & Lomb launches $3.485B credit (Apr 19 - reuters) Law Office of Brodsky & Smith, LLC Announces Investigation of ISTA Pharmaceuticals, Inc. (Apr 03 - reuters) ISTA Pharmaceuticals: Cost Cutting And A $9.10 A Share Takeover Offer From Bausch & Lomb (Mar 30 - reuters) The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of ISTA Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bausch + Lomb (Mar 29 - reuters) TEXT-Moody's comments on Bausch & Lomb (Mar 28 - reuters) Law Offices of Howard G. Smith Announces Continued Investigation of ISTA Pharmaceuticals, Inc. (Mar 28 - reuters) Law Firm Brower Piven Announces Investigation in Connection With the Acquisition of ISTA Pharmaceuticals, Inc. by Bausch + Lomb (Mar 28 - reuters) TEXT-S&P:Bausch & Lomb deal for Ista will not affect rtgs (Mar 28 - reuters) Glancy Binkow & Goldberg LLP Announces Continued Investigation of ISTA Pharmaceuticals, Inc. (Mar 28 - reuters) The Law Firm of Weiss & Lurie Investigates ISTA Pharmaceuticals, Inc. (Mar 28 - reuters) The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of ISTA Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bausch + Lomb (Mar 28 - reuters) Harwood Feffer LLP Announces Investigation of ISTA Pharmaceuticals, Inc. (Mar 27 - reuters) Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of ISTA Pharmaceuticals, Inc. (Mar 27 - reuters) Third Time's the Charm for This Small-Cap Buyout (Mar 27 - reuters) ISTA Pharmaceuticals Investor Alert:The Briscoe Law Firm and Powers Taylor, LLP Investigate the Acquisition of ISTA Pharmaceuticals, Inc. by Bausch + Lomb (Mar 27 - reuters) Law Offices of Howard G. Smith Announces Investigation of ISTA Pharmaceuticals, Inc. (Mar 27 - reuters) Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ista Pharmaceuticals Inc. (Mar 27 - reuters) Bernstein Liebhard LLP Announces Investigation of Acquisition of ISTA Pharmaceuticals, Inc. by Bausch + Lomb (Mar 27 - reuters) Ryan & Maniskas, LLP Announces Investigation of ISTA Pharmaceuticals, Inc. (Mar 27 - reuters) ISTA Pharmaceuticals Gets The Bid It Wants (Mar 27 - reuters) ISTA Pharmaceuticals Announces Issuance of U.S. Patent for PROLENSA(TM) (Mar 27 - reuters) Block & Leviton LLP Investigates ISTA Pharmaceuticals, Inc.'s Board of Directors for Possible Breaches of Fiduciary Duty (Mar 27 - reuters) Glancy Binkow & Goldberg LLP Announces Investigation of ISTA Pharmaceuticals, Inc. (Mar 27 - reuters) Bausch + Lomb to Acquire ISTA Pharmaceuticals (Mar 27 - reuters) The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of ISTA Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bausch + Lomb (Mar 27 - reuters) UPDATE 1-Bausch & Lomb to buy Ista for $500 mln (Mar 27 - reuters) ISTA Pharmaceuticals Announces Settlement on Royalty Dispute (Mar 26 - reuters) ISTA Pharmaceuticals Misses on Revenues but Beats on EPS (Feb 25 - reuters) ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2011 Financial Results (Feb 23 - reuters) 2-Star Stocks Poised to Plunge: ISTA Pharmaceuticals? (Feb 16 - reuters) ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2011 Financial Results (Feb 09 - reuters) ISTA Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study of BEPOSONE(TM) (Bepotastine Besilate - (Jan 30 - reuters) Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc. (Jan 30 - reuters) Valeant sweetens takeover bid, ISTA shares surge (Jan 17 - reuters) UPDATE 2-ISTA says Valeant raises offer price (Jan 17 - reuters) ISTA Pharmaceuticals Announces Adoption of a Replacement Stockholders Rights Plan (Jan 17 - reuters) Valeant Pharmaceuticals Increases Proposed Price for Acquisition of ISTA Pharmaceuticals Inc. to $7.50 Per Share in Cash (Jan 17 - reuters) UPDATE 1-ISTA says Valeant raises offer price (Jan 17 - reuters) ISTA's Board of Directors to Review Valeant's Revised Proposal as Part of Its Ongoing Review of Strategic Options (Jan 17 - reuters) Valeant Bid Opens Eyes On ISTA Pharmaceuticals' Value (Dec 30 - reuters) 3 Stocks Shaking the Market (Dec 19 - reuters) 5 Stocks Posting Big Jumps Last Week (Dec 19 - reuters) This Week's Top Stock Gainers (Dec 17 - reuters) 5 Stocks Under $10 Set to Soar (Dec 16 - reuters)

ADS

MY PORTFOLIO



GAIN vs LOSS


BEST vs WORST


SELECTION DIY

Market Cap
Last Trade
Gain/Loss
Webtech:
P / E
EPS
market cap / total revenue
TOT REV 1 / TOT REV 2
NET INC 1 / NET INC 2
MED NET INC / MED TOT REV
NET INCOME / MARKET CAP
totalRev1/totalRev3
net inc1/net inc3
tot rev 2/ tot rev 3
net inc 2 / net inc 3
.
MARKET CAP / NET TANGIBLE ASSETS
MARK CAP/TOT STOCK EQ
market cap / tot current assets
TOT CURR ASSETS / TOT LIAB
.
SELL HOLD BUY